Introduction: Physicians find it difficult to announce the diagnosis of Covid-19 and often resort to the advice of a psychiatrist. This is due to the fear of the patients reaction and the negative psychological impact that the announcement would cause, the poorly known evolution of this pathology and to the lack of training regarding Covid-19 diagnosis announcement practices. The purpose of our study is trying to better understand the current practice and the difficulties encountered during the Covid-19 diagnosis announcement as well as evaluating the patients general reactions. Material and Methods: Quantitative, descriptive and analytical, cross-sectional study based on an online questionnaire. Results: 114 physicians filled in our questionnaire. More than half of them had not received any training regarding Covid-19 dignosis announcement. 94.7% of the physicians believe that it is necessary to announce the diagnosis of Covid-19, most of them considering it as an asset in their disease management. The reluctance to announce a disease with a severe prognosis, along with the fear of negative social and therapeutic repercussions, would slow down clinicians in their practice. Although most clinicians provide a variety of information (clinical, therapeutic, prognostic, target symptoms, and treatment side effects), the majority of participants were satisfied with the information they provide to Covid+ patients. Conclusion: A framework for the diagnostic process, training dedicated to the announcement and the use of material aids should be considered in order to limit these difficulties and to support physicians in their practice. In this respect, primary care physicians are almost unanimous in their desire for specific training.

IntroductionDiscovered in December 2019, COVID has affected the entire planet, through direct exposure to its virus; SARS-COV-2, or indirectly through the media, Indeed, on January 20, 2020, the World Health Organization declared COVID-19 to be “a public health emergency of international concern.” Along with other public health crises and other collective trauma (terrorism, H1N1 epidemic or SARS-COV), exposure to publicized information on this virus generates psychiatric disorders, in particular anxiety and absence of well-being. Objective: To link exposure to information about this pandemic through social media and anxiety and lack of well-being.ObjectivesExplore the relationship between anxiety, well-being and exposure to social mediasMethodsUse of a questionnaire consisting of three sections, individual status and conditions, the French versions of the GAD-7 scale for anxiety (Generalized anxiety scale of 7items) and the WHO-5 (five well-being index). This questionnaire is dedicated to the general population who have not been in direct contact with the virus, but through the media.ResultsWe were able to collect 209 participants, they were essentially females with a mean age of 28yo, 17,7% had psychiatric history of anxiety and depression, the median use of social medias was 5.7 hours per day. And they were essentially getting their information about the pandemic from Instagram, Facebook, the Moroccan ministry of health’s website and electronic newspapers. 31,1% of our participants had anxiety which was above a Chinese study, and had a poor well-being.ConclusionsThe use of social media to get information about the pandemic had an impact on well-being and anxiety.DisclosureNo significant relationships.

Introduction: On March 11th 2020, the World Health Organization declared the infection of the virus severe acute respiratory syndrome coronavirus 2 or SARS-COV-2 a pandemic. The virus, which was first discovered in China in Wuhan province in December 2019, has affected more than 100 million people and more than two million deaths in more than 200 countries.Along with other epidemics and pandemics, the existence of this virus has led to psychiatric disorders in people in or without direct contact with the disease, especially frontline healthcare workers. Objective: To assess the impact of the virus on medical personnel working in Morocco, in particular stress, depression and sleep disorders. Methodology: To explore this topic, we used an anonymity questionnaire based on, in addition to individual status and conditions, scales assessing stress, depression and sleep.The questionnaire was sent via social networks to health personnel working in Morocco in the various hospitals and departments treating patients infected with this virus.The CES-D (Center of Epidemiological Studies - Depression) scales for depression, the PSS-10 (Cohens Perceived Stress Scale) for perceived stress and ISI (C. Morins Insomnia Severity Index) for disorders of sleep, were chosen given their frequent use in a number of studies on the same topic. Results: After sorting our responsesrigorously, we were able to collect 376 responses, of which 53.5% were women, with an average age of 28.45 years, 23.9% were nurses, 14.4% general practitioners, 19, 7% of internal doctors 37.2% of residents or specialists and 4.8% occupied other functions such as medical transport. 66% of our candidates were at the level of the different university hospital centers of Morocco.Our candidates respectively occupied 39.1% 28.2% 29% and 25.8% triage positions, observation of suspected cases, the COVID sector and resuscitation.Regarding our results, it was observed that 71% of our participants presented moderate stress, 44.9% had a risk of developing depression and 53.7 had insomnia of varying severity.The female sex, the lack of medical, surgical and psychiatric history influence the occurrence of the three abnormalities studied, it should also be noted that these last three maintain a relationship of influences between them. Conclusion: The exploration of stress, depression and insomnia revealed an impact of the state of health on the daily life of front-line health workers in Morocco.

Background: Other than being a neurological condition, medically-induced dystonia is a frequently observed side effect by psychotropic drugs. One of the most challenging aspects is the fact that it can be triggered by other drugs not used by psychiatrists. Which makes it hard to detect and treat. Case Report: We report, through this case-report, a patient after diagnosing a gastric illness taking metoclopramide as a symptomatic medication, then presenting oro-mandibulary dystonia which imitated a panic attack and led to mistreatment. Conclusion: Medically-induced dystonia are not reported enough in developing countries even though they are frequent. This case shows the importance of knowing and being prepared to all side effects on the prescribed drugs, most importantly those over-the-counter.

Background: The neuroleptic malignant syndrome (NMS) is an idiosyncratic abnormality due to the use of dopamine antagonists. The most incriminated are antipsychotics, these drugs can be classified according to the incidence of this iatrogenic event. Amisulpride and Risperidone are not on the top of the list; they are not reported sufficiently in the literature because of the rarity of the event. Case presentation: We report, through this case-report, a patient who had two successive episodes of NMSs, this is a rare event in psychiatric practice that let us take in consideration the genetic hypothesis of individual vulnerability. In addition, the plasmatic creatine kinase being at 50,000 iu/l is not very common and put our patient in a life-threatening situation. Conclusion: Although being rare, the neuroleptic malignant syndrome can occur multiple time in the same patient, having two NMS, a high ck plasmatic level, and dealing with its complications leads us more towards the genetic theory.